SCHEMBL9309518

SCHEMBL9309518

CCc1nc(Cl)c(C(=O)O)n1Cc1c2ccocc-2c(Br)c1-c1ccccc1-c1nnn[nH]1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 5/20 0.38
AGTR2 P50052 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9309262 0.94 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL3473992 0.93 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9616614 0.92 AGTR1 (0.32) AGTR1AGTR2
Water SCHEMBL9311609 0.92 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9310782 0.92 AGTR1 (0.32) AGTR1AGTR2
SCHEMBL9859908 0.92 AGTR1 (0.32) AGTR1AGTR2
SCHEMBL9693628 0.91 AGTR1 (0.32) AGTR1AGTR2
SCHEMBL9309949 0.91 AGTR1 (0.34) AGTR1AGTR2
Hydrochloric Acid SCHEMBL9309853 0.91 AGTR1 (0.31) AGTR1AGTR2
SCHEMBL9311445 0.91 AGTR1 (0.33) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5374646-A Treatment or prophylasix of hypertension and diseases associated with cognitive disorders GLAXO GROUP LIMITED (GB) 1994-12-20 US claimed
EP-0434249-A2 Benzofuran derivatives GLAXO GROUP LIMITED (GB) 1991-06-26 EP claimed
US-5374646-A Treatment or prophylasix of hypertension and diseases associated with cognitive disorders GLAXO GROUP LIMITED (GB) 1994-12-20 US disclosed
EP-0434249-A2 Benzofuran derivatives GLAXO GROUP LIMITED (GB) 1991-06-26 EP disclosed